BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsu CY, Wang CW, Cheng AL, Kuo SH. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness. World J Gastrointest Oncol 2019; 11(8): 579-588 [PMID: 31435460 DOI: 10.4251/wjgo.v11.i8.579]
URL: https://www.wjgnet.com/1007-9327/full/v11/i8/579.htm
Number Citing Articles
1
Yu-Lun Tsai, Hideyuki Takei, Takashi Iizumi, Toshiyuki Okumura, Yuta Sekino, Haruko Numajiri, Hitoshi Ishikawa, Takeji Sakae, Hideyuki Sakurai. Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinomaJournal of Radiation Research 2021; 62(1): 133 doi: 10.1093/jrr/rraa098
2
Luca Cozzi, Tiziana Comito, Mauro Loi, Antonella Fogliata, Ciro Franzese, Davide Franceschini, Elena Clerici, Giacomo Reggiori, Stefano Tomatis, Marta Scorsetti. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-EscalationTechnology in Cancer Research & Treatment 2020; 19: 153303382098041 doi: 10.1177/1533033820980412
3
M V Troshina, K G Vasilev, E V Koryakina, V I Potetnya, A N Solovev, O Yu Golovanova, S N Koryakin. Biological efficiency of ultra- and hypofractionated irradiation of a proton scanning beamJournal of Physics: Conference Series 2020; 1701(1): 012028 doi: 10.1088/1742-6596/1701/1/012028
4
Belal Abousaida, Cheng-en Hsieh, Bhanu P. Venkatesulu, Sunil Krishnan. Radiotherapy of Liver Cancer2021; : 73 doi: 10.1007/978-981-16-1815-4_6